Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

Launched by PICTERUS AS · Aug 26, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new smartphone-based tool called Picterus JP, designed to help doctors measure bilirubin levels in newborns with jaundice. Jaundice is a condition that causes yellowing of the skin and eyes in babies due to high bilirubin levels in their blood. The goal of this study is to find a way to accurately assess these levels regardless of the baby's skin color, making it easier and more reliable for healthcare providers to monitor and treat jaundice.

To take part in this trial, infants must be between 1 and 14 days old, born after 35 weeks of pregnancy, and weigh at least 1800 grams. They should also need a standard blood test for jaundice as part of their regular care. However, babies with certain medical conditions, skin issues, or those who have recently received treatment for jaundice are not eligible. Participants can expect to have their bilirubin levels assessed using the Picterus JP tool, which may offer a quick and non-invasive way to monitor their condition. This study is currently seeking participants at the University of Chicago Medicine and aims to improve how jaundice is diagnosed and managed in newborns.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants born with gestational age \> 35 weeks.
• • Birth weight ≥ 1800 grams
• • Age 1 - 14 days
• • Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care
• Exclusion Criteria:
• • Infants showing signs of inborn disease.
• • Infants with skin rash or other skin disease that affects the skin where measurements are performed.
• • Infants transferred to the pediatric ward for medical treatment.
• • Infants that have received phototherapy in the last 24 hours